ID NOW™ is a leading molecular point-of-care platform in the United States, trusted by hospitals, physician offices, and urgent care clinics nationwide.
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near patient testing environments.
Only available in the US.
Listen to a timely educational webinar on the CARES Act, information gathering and test reporting for COVID-19 testing sites.
A simple, reliable and secure connectivity and reporting solution, offering ID NOW COVID-19 test reporting within 24 hours for decentralized environments to help you manage data for CARES Act requirements without infrastructure burden.
ID NOW Information
ID NOW COVID-19 HCP Fact Sheet
ID NOW COVID-19 Patient Fact Sheet
ID NOW COVID-19 Quick Reference Instructions
ID NOW COVID-19 Test Product Insert
ID NOW US Customer Letter
ID NOW COVID-19 Technical Brief April 2020
ID NOW COVID-19 Technical Brief May 2020
ID NOW COVID-19 Technical Brief September 2020
US Centers for Disease Control (CDC) Coronavirus (COVID-19) Webpages
General Coronavirus (COVID-19)
Healthcare Professionals Information
Information for Laboratories
Laboratory Biosafety
Isolation Precautions in Healthcare Settings
Specimen Collection
World Health Organization (WHO) Coronavirus (COVID-19)
U.S. Food & Drug Administration
Emergency Use Authorization of Medical Products and Related Authorities
| ID NOW™ System |
Code |
|---|---|
| ID NOW™ Instrument |
NAT-000 (Global) |
| ID NOW™ COVID-19 24 Test Kit | 190-000 (US) |
| ID NOW™ COVID-19 Control Kit (12 pos, 12 neg) | 190-080 (US) |
| ID NOW™ Barcode Scanner | OPR2001ZWU1-201 (Global) |
| Abbott Barcode Scanner | L22XWU1200 (US) |
| Universal Printer | 55115 (Global) |
| IDNOWPRINT, formerly alereiprinter (US) |
The ID NOW COVID-19 EUA has not been FDA cleared or approved. It has been authorized by the FDA under an
emergency use authorization for use by authorized laboratories and patient care settings. The test has been authorized only
for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the
duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic
tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the
authorization is terminated or revoked sooner.
1. Please see ID NOW Instrument User manual for additional operating environment requirements.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Not all products are available in all regions. Check with your local representative for availability in specific markets. For In Vitro Diagnostic Use Only. For the use of registered medical practitioners, hospitals and Laboratories only.
Based on your current location, the content on this page may not be relevant for your country.
